Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 9 de 9
Filter
1.
Clin Nutr ; 38(6): 2778-2782, 2019 12.
Article in English | MEDLINE | ID: mdl-30579666

ABSTRACT

BACKGROUND & AIMS: Exocrine pancreatic function is affected in patients with locally advanced pancreatic cancer (LAPC), clinically leading to steatorrhea. It is unknown whether maldigestion and malabsorption can also be attributed to impaired intestinal enterocyte function. In this exploratory study enterocyte function was assessed in patients with locally advanced pancreatic cancer, treated with Irreversible Electroporation (IRE). METHODS: Enterocyte function was studied by Citrulline Generation Test (CGT). Intestinal absorption capacity of energy and fat was calculated from the differences between nutritional intake (four-days diary) and quantified fecal losses energy and fat in three-days feces collection. RESULTS: Twelve patients were included before IRE, and 5 patients had follow-up measurements. Fasted citrulline [CIT] and glutamine [GLU] levels were below reference levels of healthy subjects ([CIT] 38 ± 8 µmol/L; [GLU] 561 ± 77 µmol/L) both before ([CIT] 25 ± 9 µmol/L; [GLU] 65 ± 35 µmol/L) and after IRE ([CIT] 19 ± 9 µmol/L; [GLU] 53 ± 26 µmol/L) whereas CGT curves were normal, indicating normal enterocyte function (slope 0.21 ± 0.12 and 0.17 ± 0.07 µmol/L/min; [CIT] increment 63 ± 39 and 80 ± 44% respectively). Severe energy/fat malabsorption was present in 6 out of 12 patients with LAPC (mean loss 349 kcal/d, 13 g fat/d) before and in 4 out of 5 patients (mean loss 509 kcal/d, 32 g fat/d) after IRE respectively. CONCLUSIONS: Enterocyte function was generally within reference limits in patients with advanced pancreatic cancer. Severe malabsorption may be explained by exocrine pancreatic insufficiency.


Subject(s)
Enterocytes/metabolism , Pancreas , Pancreatic Neoplasms , Aged , Citrulline/metabolism , Exocrine Pancreatic Insufficiency/metabolism , Exocrine Pancreatic Insufficiency/physiopathology , Fats/metabolism , Feces/chemistry , Female , Glutamine/metabolism , Humans , Intestinal Absorption/physiology , Male , Middle Aged , Pancreas/metabolism , Pancreas/physiopathology , Pancreatic Neoplasms/metabolism , Pancreatic Neoplasms/physiopathology , Prospective Studies
2.
Can Assoc Radiol J ; 69(1): 38-50, 2018 Feb.
Article in English | MEDLINE | ID: mdl-29458954

ABSTRACT

Hepatopancreaticobiliary tumours are often diagnosed at an advanced disease stage, in which encasement or invasion of local biliary or vascular structures has already occurred. Irreversible electroporation (IRE) is an image-guided tumour ablation technique that induces cell death by exposing the tumour to high-voltage electrical pulses. The cellular membrane is disrupted, while sparing the extracellular matrix of critical tubular structures. The preservation of tissue integrity makes IRE an attractive treatment option for tumours in the vicinity of vital structures such as splanchnic blood vessels and major bile ducts. This article reviews current data and discusses future trends of IRE for hepatopancreaticobiliary tumours.


Subject(s)
Ablation Techniques/methods , Electroporation/methods , Liver Neoplasms/surgery , Pancreatic Neoplasms/surgery , Humans , Liver/surgery , Pancreas/surgery
3.
Gastroenterol Res Pract ; 2017: 6193765, 2017.
Article in English | MEDLINE | ID: mdl-28912804

ABSTRACT

BACKGROUND AND AIM: To provide a comprehensive quantitative assessment of nutritional status, digestion and absorption, and quality of life (QoL) in patients with locally advanced pancreatic cancer (LAPC). METHODS: Sixteen patients with LAPC were prospectively assessed for weight loss (WL), body mass index (BMI), fat-free mass index (FFMI), handgrip strength (HGS), dietary macronutrient intake, serum vitamin levels, resting and total energy expenditure (REE and TEE, indirect calorimetry), intestinal absorption capacity and fecal losses (bomb calorimetry), exocrine pancreatic function (fecal elastase-1 (FE1)), and gastrointestinal quality of life (GIQLI). RESULTS: Two patients had a low BMI, 10 patients had WL > 10%/6 months, 8 patients had a FFMI < P10, and 8 patients had a HGS < P10. Measured REE was 33% higher (P = 0.002) than predicted REE. TEE was significantly higher than daily energy intake (P = 0.047). Malabsorption (<85%) of energy, fat, protein, and carbohydrates was observed in, respectively, 9, 8, 12, and 10 patients. FE1 levels were low (<200 µg/g) in 13 patients. Total QoL scored 71% (ample satisfactory). CONCLUSION: Patients with LAPC have a severely impaired nutritional status, most likely as a result of an increased REE and malabsorption due to exocrine pancreatic insufficiency. The trial is registered with PANFIRE clinicaltrials.gov NCT01939665.

4.
Cardiovasc Intervent Radiol ; 40(10): 1631-1640, 2017 Oct.
Article in English | MEDLINE | ID: mdl-28470395

ABSTRACT

OBJECTIVE: To describe the initial experience with irreversible electroporation (IRE) to treat pelvic tumor recurrences. METHODS: A retrospective single-center analysis was performed. Adverse events were recorded using Common Terminology Criteria of Adverse Events (CTCAE) 4.0. Clinical outcome was determined using pain- and general- symptom assessment, including Seddon's peripheral nerve injury (PNI) types. Radiological outcome was evaluated by comparing baseline with three-month 18F-FDG PET-CT follow-up. RESULTS: Eight patients (nine tumors [recurrences of primary rectal (n = 4), anal (n = 1), sigmoid (n = 1), cervical (n = 1), and renal cell carcinoma (n = 1)]) underwent percutaneous IRE as salvage therapy. Median longest tumor diameter was 3.7 cm (range 1.2-7.0). One CTCAE grade III adverse event (hemorrhage) and eight CTCAE grade II complications occurred in 6/8 patients: vagino-tumoral fistula (n = 1), lower limb motor loss (n = 3; PNI type II) with partial recovery in one patient, hypotonic bladder (n = 2; PNI types I and II) with complete recovery in one patient, and upper limb motor loss (n = 2; PNI type II) with partial recovery in both patients. No residual tumor tissue was observed at 3-month follow-up. After a median follow-up of 12 months, local progression was observed in 5/9 lesions (4/5 were >3 cm pre-IRE); one lesion was successfully retreated. Debilitating preprocedural pain (n = 3) remained unchanged (n = 1) or improved (n = 2). CONCLUSION: IRE may represent a suitable technique to treat pelvic tumor recurrences, although permanent neural function loss can occur. Complete ablation seems realistic for smaller lesions; for larger lesions symptom control should be the focus.


Subject(s)
Carcinoma, Renal Cell/therapy , Electroporation/methods , Kidney Neoplasms/therapy , Neoplasm Recurrence, Local/therapy , Rectal Neoplasms/therapy , Sigmoid Neoplasms/therapy , Uterine Cervical Neoplasms/therapy , Aged , Carcinoma, Renal Cell/diagnostic imaging , Female , Fluorodeoxyglucose F18 , Follow-Up Studies , Humans , Kidney Neoplasms/diagnostic imaging , Male , Middle Aged , Positron Emission Tomography Computed Tomography/methods , Radiopharmaceuticals , Rectal Neoplasms/diagnostic imaging , Retrospective Studies , Sigmoid Neoplasms/diagnostic imaging , Treatment Outcome , Uterine Cervical Neoplasms/diagnostic imaging
6.
Br J Anaesth ; 113(6): 985-92, 2014 Dec.
Article in English | MEDLINE | ID: mdl-25173767

ABSTRACT

BACKGROUND: Irreversible electroporation (IRE) is a novel tumour ablation technique involving repetitive application of electrical energy around a tumour. The use of pulsed electrical gradients carries a risk of cardiac arrhythmias, severe muscle contractions, and seizures. We aimed to identify IRE-related risks and the appropriate precautions for anaesthetic management. METHODS: All patients who were treated with IRE were prospectively included. Exclusion criteria were arrhythmias, congestive heart failure, active coronary artery disease, and epilepsy. All procedures were performed under general anaesthesia with complete muscle relaxation during ECG-synchronized pulsing. Adverse events, cardiovascular effects, blood samples, cerebral activity, and post-procedural pain were analysed. RESULTS: Twenty-eight patients underwent 30 IRE sessions for tumours in the liver, pancreas, kidney, and lesser pelvis. No major adverse events occurred during IRE. Median systolic and diastolic blood pressure increased by 44 mm Hg (range -7 to 108 mm Hg) and 19 mm Hg (range 1-50 mm Hg), respectively. Two transient minor cardiac arrhythmias without haemodynamic consequences were observed. Muscle contractions were mild and IRE caused no reactive brain activity on a simplified EEG. Pain in the first 24 h after percutaneous IRE was generally mild, but higher pain scores were reported after pancreatic treatment (mean VAS score 3; range 0-9). CONCLUSIONS: Side-effects during IRE on tumours in the liver, pancreas, kidney, and lesser pelvis seem mild and manageable when current recommendations for anaesthesia management, including deep muscle relaxation and ECG synchronized pulsing, are followed. Electrical pulses do not seem to cause reactive cerebral activity and evidence for pre-existing atrial fibrillation as an absolute contra-indication for IRE is questionable.


Subject(s)
Ablation Techniques/methods , Anesthesia, General/methods , Electroporation/methods , Neoplasms/surgery , Ablation Techniques/adverse effects , Aged , Arrhythmias, Cardiac/etiology , Contraindications , Electrocardiography , Electroencephalography , Female , Humans , Hypertension/etiology , Kidney Neoplasms/surgery , Liver Neoplasms/secondary , Liver Neoplasms/surgery , Male , Middle Aged , Minimally Invasive Surgical Procedures/adverse effects , Minimally Invasive Surgical Procedures/methods , Monitoring, Intraoperative/methods , Muscle Contraction , Pain Measurement/methods , Pain, Postoperative/etiology , Pancreatic Neoplasms/surgery , Pelvic Neoplasms/surgery , Perioperative Care/methods , Prospective Studies
7.
Eur Radiol ; 24(10): 2467-75, 2014 Oct.
Article in English | MEDLINE | ID: mdl-24939670

ABSTRACT

OBJECTIVES: Irreversible electroporation (IRE) is a new ablation technique that relies on high-voltage electrical pulses. This clinical study evaluates the pathological response of colorectal liver metastases (CRLM) treated with IRE and the clinical safety and feasibility. METHODS: Ten patients with resectable CRLM were included. During laparotomy, the metastases were treated with IRE and resected 60 min later. Safety and feasibility were assessed based on adverse events, laboratory values, technical success and intra-operative ultrasound findings. Tissue response was assessed using triphenyl tetrazolium chloride (TTC) vitality staining and (immuno)histochemical stainings (HE, complement-3d and caspase-3). RESULTS: Ten lesions with a mean diameter of 2.4 cm were successfully electroporated and resected, on average, 84 min later (range 51-153 min). One minor transient cardiac arrhythmia occurred during IRE. Ultrasound showed a sharply demarcated hypoechoic ablation zone around the tumour. TTC showed avitality of all lesions, covering the complete tumour in 8/10 lesions. Although immunohistochemistry proved heterogeneous and difficult to interpret within the tumours, it confirmed irreversible cell damage in the tumour-free margin of all specimens. CONCLUSIONS: This ablate-and-resect study demonstrated avitality caused by IRE of CRLM in humans. Further characterisation of tissue- and tumour-specific electrical properties is warranted to improve ablation protocols for maximised tissue ablation. KEY POINTS: • Irreversible electroporation induces cell death in colorectal liver metastases within 1 h. • The ablation zone shows a sharp demarcation between avital and vital tissue. • Apoptosis is involved in cell death of colorectal liver metastases after IRE. • Effects of IRE can be monitored real-time using intraoperative ultrasound. • Local electrical heterogeneities of tumour tissue may require tumour-specific ablation protocols.


Subject(s)
Ablation Techniques/methods , Colorectal Neoplasms/surgery , Electroporation/methods , Hepatectomy/methods , Liver Neoplasms/secondary , Surgery, Computer-Assisted/methods , Aged , Colorectal Neoplasms/pathology , Feasibility Studies , Female , Humans , Laparotomy , Liver Neoplasms/diagnosis , Liver Neoplasms/surgery , Magnetic Resonance Imaging , Male , Middle Aged , Neoplasm Staging/methods , Positron-Emission Tomography , Tomography, X-Ray Computed
8.
Clin Radiol ; 68(1): e9-e14, 2013 Jan.
Article in English | MEDLINE | ID: mdl-23146554

ABSTRACT

AIM: To describe initial clinical experience with bipolar radiofrequency ablation (RFA) for symptomatic giant hepatic haemangiomas. MATERIALS AND METHODS: Four consecutive patients with a large-volume, symptomatic hepatic cavernous haemangioma of >10 cm were treated with bipolar RFA during laparotomy with ultrasound guidance. Complications were carefully noted. Clinical and radiological effectiveness were evaluated comparing baseline with 3 and 6 months follow-up of symptom assessments and upper abdominal magnetic resonance imaging (MRI) or computed tomography (CT). RESULTS: RFA was successfully performed for all four giant haemangiomas. No major complications were observed. Peri-procedural shrinking was remarkable and intermediate-term volume reduction ranged from 58-92% after 6 months. Symptom relief after 6 months was complete in two patients and considerable in the other two. CONCLUSION: Preliminary results suggest intra-operative bipolar RFA to be a safe, feasible, and effective technique for treatment of giant symptomatic hepatic cavernous haemangiomas.


Subject(s)
Catheter Ablation/methods , Hemangioma, Cavernous/surgery , Liver Neoplasms/surgery , Abdominal Pain/etiology , Adult , Back Pain/etiology , Catheter Ablation/instrumentation , Equipment Design , Feasibility Studies , Female , Flank Pain/etiology , Hemangioma, Cavernous/pathology , Humans , Liver Neoplasms/pathology , Magnetic Resonance Imaging , Middle Aged , Tomography, X-Ray Computed , Ultrasonography, Interventional
SELECTION OF CITATIONS
SEARCH DETAIL
...